LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High-Throughput Micro-Aperture Chip System Detects Cancer Cells

By LabMedica International staff writers
Posted on 24 Oct 2013
Image: Schematic depicting a new system that uses tiny magnetic beads to quickly detect rare types of cancer cells (Photo courtesy of Bin-Da Chan, Purdue School of Mechanical Engineering).
Image: Schematic depicting a new system that uses tiny magnetic beads to quickly detect rare types of cancer cells (Photo courtesy of Bin-Da Chan, Purdue School of Mechanical Engineering).
A system is being developed that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood.

The microchip system is based on a combination of immunomagnetic separation and microfluidics for high-throughput detection of whole cells and in this system target cells bound to magnetic beads flow parallel to a microchip.

Scientists at Purdue University (West Lafayette, IN, USA) combined the two techniques of immunomagnetic separation and microfluidics. In immunomagnetic separation, magnetic beads about a micron in diameter are "functionalized," or coated with antibodies that recognize and attach to antigens on the surface of target cells. The functionalized beads recognize breast cancer and lung cancer cells in laboratory cultures.

The updated design passes the fluid through a chamber that allows for faster flow; a standard 7.5 mL fluid sample can run through the system in a matter of minutes. The beads are directed by a magnetic field to a silicon mesh containing holes 8 µm in diameter. Because the target cells are so sparse, many of the beads fail to attract any and pass through the silicon mesh. The beads that have attached to cells are too large to pass through the holes in the mesh.

The cells can be analyzed clearly under a microscope and released from the chip for further analysis by removing the magnetic field. The system was characterized by detecting human breast adenocarcinoma cell line (MCF-7) and adenocarcinomic human alveolar basal epithelial cells (A549) in culture media using anti- epithelial cell adhesion molecule (EpCAM) conjugated magnetic beads.

Cagri A. Savran, PhD, an associate professor of Biomedical Engineering at Purdue, said, “We were able to detect cancer cells with up to a 90% yield. We expect this system to be useful in a wide variety of settings, including detection of rare cells for clinical applications. What's new here is that we've built a system that can perform all of these steps on one chip. It both separates cells and also places them on a chip surface so you can count them and study them with a microscope.” The study was highlighted on September 18, 2013, in the journal Lab on a Chip.

Related Links:

Purdue University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more